argenx SE (ARGX) ADR Each Representing 1 Ord Share SPON

Sell:$743.95Buy:$745.61Price increased$14.92 (2.04%)

NASDAQ:Price increased0.99%
Market closed |
Prices delayed by at least 15 minutes
Sell:$743.95
Buy:$745.61
Change:Price increased$14.92 (2.04%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$743.95
Buy:$745.61
Change:Price increased$14.92 (2.04%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$740.06
Previous close$730.25
Market cap$43.66bn
P/E ratio37.32
Volume63,579
Dividend yield0.00%
EMS-

Company information

argenx SE, formerly arGEN X BV, is a Netherlands-based biopharmaceutical company. It is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe ...

  • LocationNetherlands
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue61.88m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.